Hikma Pharmaceuticals PLC carries a market capitalization of 4.25B, placing it among publicly traded companies globally.
| Market Cap | 4.25B |
| Enterprise Value | N/A |
Hikma Pharmaceuticals PLC's stock has declined approximately -28.07068% over the past 52 weeks. The 50-day moving average sits at 18.44, while the 200-day moving average is 20.72.
| Beta (5Y) | N/A |
| 52-Week Price Change | -28.07068% |
| 50-Day Moving Average | 18.44 |
| 200-Day Moving Average | 20.72 |
| Average Volume (20 Days) | N/A |